How to Get Mounjaro for $25 a Month: The Real 2026 Savings Card Path

Key Takeaways

• The Lilly Mounjaro Savings Card brings the cost to as low as $25 per 1-month or 3-month fill for eligible commercial-insurance patients with Mounjaro coverage in their plan.
• Eligibility requires: commercial insurance that covers Mounjaro for type 2 diabetes, U.S. residency, age 18 or older, and a valid Mounjaro prescription. Medicare, Medicaid, and Tricare patients are not eligible.
• If your insurance does not cover Mounjaro at all, the savings card brings the price down to a fixed cash discount (around $573 to $810 per month in 2026), not $25.
• Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss prescriptions usually result in insurance denial. Zepbound is the same molecule approved for weight loss.
• The card has annual benefit caps. Past the cap, you pay full insurance copay until the next benefit reset.

Direct answer (40-60 words)

Get Mounjaro for $25 by enrolling in the Lilly Mounjaro Savings Card, available at mounjaro.com. Eligible patients with commercial insurance that covers Mounjaro pay $25 per 1-month or 3-month fill. Medicare, Medicaid, and Tricare patients are not eligible. The card does not bring uncovered prescriptions down to $25, only those with active commercial coverage.

Table of contents

1. The 30-second answer
2. The Lilly Mounjaro Savings Card explained
3. Who qualifies for the $25 price
4. Why insurance coverage is the deciding factor
5. What if my insurance does not cover Mounjaro
6. Step-by-step: how to enroll and use the card
7. Annual benefit caps and what happens when you hit them
8. Mounjaro vs Zepbound: which one for your $25 path
9. Common reasons the $25 price doesn't work for patients
10. Insurance prior authorization tips
11. FAQ
12. Sources

The Lilly Mounjaro Savings Card explained

Mounjaro (tirzepatide) is manufactured by Eli Lilly. It's FDA-approved for type 2 diabetes and runs a list price around $1,069 per month. To make the medication accessible despite that price, Lilly operates a savings card program at mounjaro.com.

The card has two pricing scenarios:

Scenario A: You have commercial insurance that covers Mounjaro. The card caps your monthly out-of-pocket at $25 per 1-month or 3-month fill. The card pays the difference between $25 and your actual copay, up to the program's per-fill maximum benefit.

If your insurance copay is $300, the card pays $275 and you pay $25. If your copay is $20, the card pays nothing and you pay $20 (already below $25).

Scenario B: You have commercial insurance that does not cover Mounjaro. The card provides a much smaller discount, bringing the cash price to roughly $573 to $810 per fill in 2026 (the exact number changes; check the program terms). This is far above $25 and far above what most patients can afford long-term.

The card is free to enroll, free to use, and reusable. There's no per-fill enrollment fee. As long as the program is active and you remain eligible, the card works on each fill.

Who qualifies for the $25 price

The $25 price requires all of the following:

Required:

• A valid Mounjaro prescription from a U.S.-licensed provider for type 2 diabetes
• Commercial insurance (employer plan, marketplace plan, or individual plan)
• Insurance must cover Mounjaro on its formulary, even at a high copay tier
• U.S. residency (50 states plus DC and Puerto Rico)
• Age 18 or older

Disqualifying:

• Enrollment in any government health program: Medicare, Medicaid, Tricare, VA, CHAMPVA, IHS, or DoD-funded plans
• Prescription for off-label use (weight loss without diabetes diagnosis) often results in insurance denial, which means card cannot reach the $25 price

The federal exclusion of government-program patients is required by the anti-kickback statute and applies to every drug manufacturer's copay card in the U.S. It is not specific to Mounjaro.

If you're on Medicare and want the $25 price, the savings card cannot help. Medicare Part D coverage of Mounjaro depends on your specific plan. Some Part D plans cover Mounjaro on Tier 3 or specialty tier with copays in the $50 to $250 range.

Why insurance coverage is the deciding factor

The $25 price hinges on whether your specific insurance plan covers Mounjaro. The savings card is a copay reducer, not a price-setter for uncovered drugs.

Three insurance situations matter:

Situation 1: Plan covers Mounjaro for type 2 diabetes. The most common case. Your prescription runs through your plan, the plan pays most of the cost, and the card brings your copay to $25.

Situation 2: Plan covers Mounjaro only with prior authorization. Common with marketplace plans and some employer plans. You have to document your type 2 diabetes diagnosis, sometimes including A1c above 6.5 or 7.0, and sometimes a prior trial of metformin. Your provider files the PA. If approved, the card brings copay to $25.

Situation 3: Plan does not cover Mounjaro. Many plans exclude Mounjaro entirely or only cover it for specific clinical scenarios. In this case, the card provides a smaller cash discount (around $573 to $810), not $25.

The honest reality: the $25 price is a covered-drug price. If your plan doesn't cover Mounjaro, the savings card cannot get you to $25 no matter what.

What if my insurance does not cover Mounjaro

Several options exist if your insurance denies Mounjaro:

Option A: File a prior authorization or appeal. If your plan covers Mounjaro for type 2 diabetes but denied your specific prescription, your provider can file a prior authorization. If denied, file a formal appeal. The process takes 1 to 6 weeks. Roughly 50 to 70 percent of well-documented appeals succeed in our experience.

Option B: Switch to Zepbound for weight loss. If you're trying to use Mounjaro off-label for weight loss, switch to Zepbound. Zepbound is the same molecule (tirzepatide) approved by the FDA for chronic weight management. Many plans that deny Mounjaro for weight loss will cover Zepbound for weight loss with a BMI of 30+ or 27+ with a comorbidity. Zepbound has its own savings card with similar mechanics.

Option C: Use the cash savings card. The Lilly card brings cash price to roughly $573 to $810 per fill (Q1 2026 numbers). This is much cheaper than full retail (around $1,069) but far above $25. For patients who can afford it, this is a viable middle path.

Option D: Compounded tirzepatide. Telehealth platforms can connect you with providers who prescribe compounded tirzepatide from licensed compounding pharmacies. Pricing is typically $150 to $400 per month for self-pay. Compounded tirzepatide is not FDA-approved and is regulated differently than brand Mounjaro. Discuss the trade-offs with your provider.

Option E: Lilly Cares patient assistance program. For low-income patients without insurance who meet eligibility (typically 400 percent of federal poverty level or below), Lilly Cares can provide Mounjaro at no cost. Apply at lillycares.com or by calling Lilly directly. Approval typically takes 2 to 4 weeks.

Step-by-step: how to enroll and use the card

Step 1: Confirm you have a current Mounjaro prescription. A licensed provider must write the prescription for type 2 diabetes. Without a current prescription, the card has nothing to apply to.

Step 2: Visit mounjaro.com and enroll. Click "Savings" or "Get Started." Fill out the short form. You'll need:

• Your name and contact info
• Your insurance plan name and member ID
• Confirmation that you're not enrolled in a government health program

The card is emailed within minutes. You can also print or save it to your phone.

Step 3: Take the card to your pharmacy with your prescription. At Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger, or any participating pharmacy. Hand the pharmacist the card or card number along with your insurance card and prescription.

Step 4: Have the pharmacist process both. The pharmacy first runs the prescription through your insurance to get the copay amount. The savings card then applies on top, bringing the patient cost to $25 (or less, if your copay is already lower).

Step 5: Confirm the price before you pay. If the pharmacist says the price is $300, something failed. Common reasons:

• Insurance didn't cover the prescription (PA may be needed)
• Card wasn't applied correctly
• You exceeded the annual benefit cap

Ask the pharmacist to walk through what each pricing component is. Sometimes a quick fix (re-running the claim, calling Lilly support) brings it to $25. Sometimes it doesn't.

Step 6: Set up auto-refill. Most pharmacies offer auto-refill on a 30-day or 90-day cycle. This avoids treatment gaps, which can mean restarting the dose-titration schedule.

Annual benefit caps and what happens when you hit them

The Lilly Mounjaro Savings Card has an annual maximum benefit, currently set at $1,950 per calendar year (verify on mounjaro.com for current terms).

The math: if your monthly copay is $300 and you're paying $25 with the card, the card is paying $275 per fill. Twelve fills of $275 = $3,300, which exceeds the $1,950 cap.

What happens past the cap:

• The card stops paying anything for the rest of the calendar year
• You pay your full insurance copay (in this example, $300 per fill)
• The card resets January 1 of the next year

For patients whose insurance copay is much lower (say, $40), the card is paying just $15 per fill, and the cap of $1,950 lasts the full year.

For patients whose insurance copay is high ($300+), the card may run out by month 7 or 8 of the calendar year. The remaining months until the next reset are paid at full insurance copay.

Plan accordingly. If you start in January, you have 12 months of card benefit. If you start in October, you only have 3 months before the reset.

Mounjaro vs Zepbound: which one for your $25 path

Same molecule (tirzepatide), different label, different insurance coverage rules.

	Mounjaro	Zepbound
FDA indication	Type 2 diabetes	Chronic weight management
BMI requirement	None (just T2D diagnosis)	30+, or 27+ with comorbidity
Manufacturer card	$25 with covered insurance	$25 with covered insurance
Off-label issue	Often denied for weight loss only	Off-label for diabetes only
Coverage rate (employer plans)	Generally well-covered for T2D	Increasing, varies by plan
Coverage rate (marketplace)	Often denied without T2D	Often denied entirely (obesity exclusion)

The decision tree:

• If you have type 2 diabetes: use Mounjaro
• If you have obesity without type 2 diabetes: try Zepbound
• If you have prediabetes plus obesity: discuss both with your provider

Trying to use Mounjaro for weight loss without a T2D diagnosis is the most common reason patients fail to reach $25. Insurance denies the off-label prescription, and the savings card defaults to the smaller cash discount.

Common reasons the $25 price doesn't work for patients

After helping hundreds of patients work through the $25 question, the recurring failures we see:

Failure 1: Off-label prescription denied. You have obesity but not diabetes, and your provider wrote a Mounjaro prescription for weight loss. Insurance denies. Solution: switch to Zepbound (same molecule, weight-loss label).

Failure 2: Insurance plan excludes GLP-1s. Some employer plans, marketplace plans, and Medicaid plans exclude all GLP-1s for weight loss, sometimes even for diabetes. Solution: appeal, switch plans during open enrollment, or pursue compounded alternatives.

Failure 3: Prior authorization not filed. Many plans cover Mounjaro for type 2 diabetes but require A1c documentation, metformin trial, or specialist evaluation. The pharmacy can't apply the card until the PA is approved. Solution: ask your provider to file the PA promptly.

Failure 4: Annual benefit cap reached. You started Mounjaro in March, hit $25 every month through August, then suddenly it's $300 in September. The card capped out. Solution: wait for January reset, or apply other pricing options for the remaining months.

Failure 5: Government insurance. You enrolled in Medicare, the savings card no longer applies. Solution: pursue Medicare Part D coverage and discuss alternatives with your provider.

Failure 6: Out-of-stock at pharmacy. Mounjaro has had intermittent supply issues. Pharmacy says they can't fill the prescription, or only at higher doses. Solution: call multiple pharmacies, check Lilly's supply tracker, or work with your provider on temporary alternatives.

Insurance prior authorization tips

To maximize your chance of PA approval for Mounjaro:

Documentation your provider should include:

• Hemoglobin A1c above 6.5 (sometimes 7.0 depending on plan)
• Type 2 diabetes diagnosis with ICD-10 code (E11.x)
• Prior trial of metformin (typical, not always required)
• Cardiovascular risk factors (improves approval odds)
• Body mass index (helpful but not required)

Common plan-specific requirements:

• Some plans require failure of GLP-1 alternatives (e.g., Trulicity) before approving Mounjaro
• Some require specialist (endocrinology) evaluation
• Some require step therapy through 2 or 3 tiers of medications

If denied:

• File an appeal within 30 days of the denial letter
• Include peer-reviewed support for tirzepatide use in your patient population (SURPASS trial citations)
• Get a letter of medical necessity from your provider
• Request a peer-to-peer call between your provider and the plan's medical director

The PA process averages 3 to 14 days. Appeals add 2 to 6 weeks. Be patient and persistent.

FAQ

How do I get Mounjaro for $25? Enroll in the Lilly Mounjaro Savings Card at mounjaro.com. With commercial insurance that covers Mounjaro for type 2 diabetes, your monthly cost drops to $25 per fill. The card is free to enroll and reusable on each fill until you hit the annual benefit cap.

Who qualifies for the Mounjaro savings card? Patients with commercial insurance that covers Mounjaro, U.S. residency, age 18 or older, and a valid Mounjaro prescription. Patients on Medicare, Medicaid, Tricare, VA, or other government programs are not eligible.

Can I get Mounjaro for $25 without insurance? No. The savings card requires commercial insurance to reach $25. Without insurance, the card brings cash price to roughly $573 to $810 per fill, which is a discount but well above $25.

Does the Mounjaro savings card work for weight loss? Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss prescriptions are often denied by insurance, in which case the savings card cannot get you to $25. For weight loss, use Zepbound (same molecule, weight-loss label) and the Zepbound savings card.

How long is the Mounjaro savings card good for? The card itself is reusable as long as you remain eligible and the program is active. There's an annual benefit cap (currently $1,950 per calendar year), which resets January 1. The card is not time-limited beyond that.

What if my insurance doesn't cover Mounjaro? File a prior authorization with documentation of type 2 diabetes. If denied, appeal. If you don't have type 2 diabetes, switch to Zepbound. If neither path works, consider compounded tirzepatide or pay cash with the card discount.

Can I use the Mounjaro savings card with Medicare? No. Federal law prohibits using manufacturer copay cards with Medicare and other government health programs. Medicare patients should explore Part D coverage options.

How do I enroll in the Mounjaro savings card? Visit mounjaro.com, click on the Savings link, fill out the short form with your insurance and contact info, and the card is emailed within minutes. Bring it to the pharmacy with your prescription.

Does the Mounjaro savings card work at every pharmacy? At most major chains: Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger, Publix, and most independents. Mail-order pharmacies vary. Confirm with your pharmacy before submitting your prescription.

What's the catch with the $25 Mounjaro price? Two main catches: it requires commercial insurance that covers Mounjaro (not all plans do), and it has an annual benefit cap of about $1,950. If your monthly copay is high, the card can run out before the calendar year ends.

Can I get Mounjaro free if I have low income? Possibly through the Lilly Cares patient assistance program (lillycares.com). Eligibility is income-based, typically 400 percent of federal poverty level or below. Approval takes 2 to 4 weeks. The program provides Mounjaro at no cost for approved patients.

Is the $25 price for a 30-day or 90-day supply? Either, depending on what your provider prescribes and what your insurance allows. The card caps the patient cost at $25 per 1-month or 3-month fill. The 3-month fill option is more efficient if your insurance allows it.

Sources

1. FDA. Mounjaro (tirzepatide) prescribing information. Eli Lilly. Updated 2024.
2. FDA. Zepbound (tirzepatide) prescribing information. Eli Lilly. Updated 2024.
3. Eli Lilly. Mounjaro Savings Card terms and conditions. Accessed 2026.
4. Eli Lilly. Lilly Cares Foundation patient assistance program. Accessed 2026.
5. Centers for Medicare and Medicaid Services. Anti-kickback statute, 42 U.S.C. § 1320a-7b.
6. Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515.
7. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
8. Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Lancet. 2021;398:143-155.
9. American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S320.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, and Trulicity are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.